Bridgeway Capital Management, LLC Hcw Biologics Inc. Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.29 - $1.28 $14,499 - $64,000	-50,000 Reduced 59.03%	34,700 $14,000
Q4 2023 Feb 14, 2024	BUY	$0.92 - $2.14 $1,932 - $4,494	2,100 Added 2.54%	84,700 $104,000
Q1 2023 May 15, 2023	BUY	$1.12 - $2.19 $11,200 - $21,900	10,000 Added 13.77%	82,600 $115,000
Q2 2022 Aug 15, 2022	BUY	$1.96 - $3.17 $31,360 - $50,720	16,000 Added 28.27%	72,600 $160,000
Q1 2022 May 16, 2022	BUY	$1.9 - $2.73 $19,000 - $27,300	10,000 Added 21.46%	56,600 $155,000
Q4 2021 Feb 14, 2022	BUY	$2.32 - $4.73 $108,111 - $220,418	46,600 New	46,600 $108,000

42.7K

Ticker HCWB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,833,100
Market Cap $161M
Description
HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.